Back

Oxysterols: a new tool to stratify toxicity in cardio-oncology

20 June 2026 (08:30 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session (2) Stratification, Prevention and Monitoring CCO Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Miss Alix Andre

Paris Saclay University, Paris (France)

40 More presentations in this session

Presentation thumbnail
Absence of detectable cardiotoxicity with L-Annamycin despite high cumulative anthracycline exposure
Mr S. Waymack (Blacksburg, US)
Abstract Slides
Presentation thumbnail
Pre-existing cardiovascular disease at cancer diagnosis: national trends and future projections in england
Mr A. Alshahrani (Riyadh, SA)
Abstract Slides
Presentation thumbnail
Causal analysis of radiation dose to the base of the heart and overall survival in lung cancer using targeted maximum likelihood estimation
Mr B. Jiang (Manchester, GB)
Abstract Slides
Presentation thumbnail
High prevalence of embolic complications among cancer patients with non-bacterial thrombotic endocarditis
Doctor M. Merhi (Berlin, DE)
Abstract Slides
Presentation thumbnail
Cardio-oncology in breast cancer patients: descriptive data from a north african cohort
Doctor E. Bennour Ep Rabah (Tunis, TN) Doctor M. Elelmi (Tunis, TN)
Abstract Slides

Access the full session

Session thumbnail
Poster session (2)

The Event

Event poster

ESC Cardio-Oncology 2026

20 June 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
In vitro platform to model anthracycline-induced cardiotoxicity and evaluate cardioprotective agents in human -induced pluripotent stem cells-derived cardiomyocytes
20 June 2025
thumbnail
Congress Presentation
Lipidomic, plasma and flow cytometry signatures enhance the classification of patients with advanced CVD and CKM syndrome
1 September 2025
thumbnail
Congress Presentation
Cardiovascular risk stratification in cancer survivors: time for a better approach?
21 June 2025
thumbnail
Webinar
ACVC Biomarker Talk Series - Cardiac biomarkers in the field of cardio-oncology
19 October 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources